GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $11,452,000 | +84.3% | 1,980 | +80.0% | 0.36% | +104.6% |
Q1 2022 | $6,215,000 | +207066.7% | 1,100 | +316.7% | 0.17% | – |
Q4 2021 | $3,000 | -92.1% | 264 | – | 0.00% | -100.0% |
Q3 2021 | $38,000 | -5.0% | 0 | – | 0.02% | +28.6% |
Q2 2021 | $40,000 | +207.7% | 0 | – | 0.01% | – |
Q1 2021 | $13,000 | +550.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2020 | $2,000 | -100.0% | 56 | -64.3% | 0.00% | -88.9% |
Q1 2020 | $5,948,000 | +8161.1% | 157 | -80.7% | 0.02% | -64.0% |
Q4 2019 | $72,000 | +105.7% | 812 | -1.3% | 0.05% | +66.7% |
Q3 2019 | $35,000 | +9.4% | 823 | +3.0% | 0.03% | +15.4% |
Q2 2019 | $32,000 | +52.4% | 799 | +62.7% | 0.03% | +52.9% |
Q1 2019 | $21,000 | -8.7% | 491 | -17.5% | 0.02% | -29.2% |
Q3 2018 | $23,000 | +64.3% | 595 | +76.6% | 0.02% | +84.6% |
Q2 2018 | $14,000 | +7.7% | 337 | +2.4% | 0.01% | 0.0% |
Q1 2018 | $13,000 | – | 329 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |